The goal of this proposal is to further develop our magneto-endosymbiont (ME) technology for in vivo single cell MRI detection (Phase 1) and functional reporting (Phase 2) thus creating a robust translational tool for cell based research. MEs were derived from magnetic bacteria creating a living contrast agent that enables in vivo cell tracking. MRI is a highly translatable technique for visualizing implanted cells because it is non- invasive and provides extremely high anatomical resolution. MEs are a unique contrast agent because they have a large genetic capacity that can be leveraged to encode functional reporters, in vivo. The effectiveness of MEs for single cell tracking will be experimentally assessed in a metastatic brain cancer model, that we have previously used to demonstrate single cell MRI tracking with superparamagnetic iron oxide particles. Tools that provide insight into detailed cellular events at the single cell level in situ will advance oncology research, regenerative medicine research, personalized diagnostics and the clinical realization of cell therapies.

Public Health Relevance

Better translational tools for preclinical research are highly needed. Understanding detailed cellular events of transplanted cells at a single cell level in situ will advance oncology research, regenerative medicine research, personalized diagnostics and the clinical realization of cell therapies. The achievement of this requires simultaneously addressing: 1) where are transplanted cells located (i.e. cell tracking) and 2) what are they doing (i.e. functional reporting). Bell Biosystems Inc. and the Rutt Group at Stanford University have created a unique collaboration to develop MRI based tools that enable researchers to answer these important questions.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43TR001202-01
Application #
8832663
Study Section
Special Emphasis Panel (ZRG1-SBIB-T (10))
Program Officer
Tagle, Danilo A
Project Start
2015-03-23
Project End
2015-09-23
Budget Start
2015-03-23
Budget End
2015-09-23
Support Year
1
Fiscal Year
2015
Total Cost
$224,679
Indirect Cost
Name
Bell Biosystems, Inc.
Department
Type
DUNS #
831183053
City
San Francisco
State
CA
Country
United States
Zip Code
94107
Brewer, Kimberly D; Spitler, Ryan; Lee, Kayla R et al. (2018) Characterization of Magneto-Endosymbionts as MRI Cell Labeling and Tracking Agents. Mol Imaging Biol 20:65-73
Lee, Kayla R; Wakeel, Abdul; Chakraborty, Papia et al. (2018) Cell Labeling with Magneto-Endosymbionts and the Dissection of the Subcellular Location, Fate, and Host Cell Interactions. Mol Imaging Biol 20:55-64